ABSTRACT
Bone health starts with maternal health and nutrition, which influences bone mass and density already in utero. The mechanisms underlying the effect of the intrauterine environment on bone health are partly unknown but certainly include the 'foetal programming' of oxidative stress and endocrine systems, which influence later skeletal growth and development. With this narrative review, we describe the current evidence for identifying patients with risk factors for developing osteopenia, today's management of these populations, and screening and prevention programs based on gestational age, weight, and morbidity. Challenges for bone health prevention include the need for new technologies that are specific and applicable to pregnant women, the foetus, and, later, the newborn. Radiofrequency ultrasound spectrometry (REMS) has proven to be a useful tool in the assessment of bone mineral density (BMD) in pregnant women. Few studies have reported that transmission ultrasound can also be used to assess BMD in newborns. The advantages of this technology in the foetus and newborn are the absence of ionising radiation, ease of use, and, above all, the possibility of performing longitudinal studies from intrauterine to extrauterine life. The use of these technologies already in the intrauterine period could help prevent associated diseases, such as osteoporosis and osteopenia, which are characterised by a reduction in bone mass and degeneration of bone structure and lead to an increased risk of fractures in adulthood with considerable social repercussions for the related direct and indirect costs.
Subject(s)
Bone Diseases, Metabolic , Osteoporosis , Infant, Newborn , Pregnancy , Humans , Female , Bone Density , Bone Diseases, Metabolic/diagnosis , Bone Diseases, Metabolic/etiology , Bone Diseases, Metabolic/prevention & control , Risk Factors , VitaminsABSTRACT
The conjugation of photoactive benzophenone with diphenylalanine yielded a self-assembling photocatalyst that was probed in the E â Z photoisomerisation of stilbene derivatives.
Subject(s)
Dipeptides , Nanostructures , Phenylalanine , BenzophenonesABSTRACT
Short-bowel syndrome (SBS) in pediatric age is defined as a malabsorptive state, resulting from congenital malformations, significant small intestine surgical resection or disease-associated loss of absorption. SBS is the leading cause of intestinal failure in children and the underlying cause in 50% of patients on home parental nutrition. It is a life-altering and life-threatening disease due to the inability of the residual intestinal function to maintain nutritional homeostasis of protein, fluid, electrolyte or micronutrient without parenteral or enteral supplementation. The use of parenteral nutrition (PN) has improved medical care in SBS, decreasing mortality and improving the overall prognosis. However, the long-term use of PN is associated with the incidence of many complications, including liver disease and catheter-associated malfunction and bloodstream infections (CRBSIs). This manuscript is a narrative review of the current available evidence on the management of SBS in the pediatric population, focusing on prognostic factors and outcome. The literature review showed that in recent years, the standardization of management has demonstrated to improve the quality of life in these complex patients. Moreover, the development of knowledge in clinical practice has led to a reduction in mortality and morbidity. Diagnostic and therapeutic decisions should be made by a multidisciplinary team that includes neonatologists, pediatric surgeons, gastroenterologists, pediatricians, nutritionists and nurses. A significant improvement in prognosis can occur through the careful monitoring of nutritional status, avoiding dependence on PN and favoring an early introduction of enteral nutrition, and through the prevention, diagnosis and aggressive treatment of CRSBIs and SIBO. Multicenter initiatives, such as research consortium or data registries, are mandatory in order to personalize the management of these patients, improve their quality of life and reduce the cost of care.
Subject(s)
Quality of Life , Short Bowel Syndrome , Child , Humans , Short Bowel Syndrome/complications , Short Bowel Syndrome/prevention & control , Intestine, Small , Intestines , Parenteral Nutrition/adverse effects , Parenteral Nutrition/methods , Multicenter Studies as TopicABSTRACT
The Brain is vulnerable to numerous insults that can act in the pre-, peri-, and post-natal period. There is growing evidence that demonstrate how oxidative stress (OS) could represent the final common pathway of all these insults. Fetuses and newborns are particularly vulnerable to OS due to their inability to active the antioxidant defenses. Specific molecules involved in OS could be measured in biologic fluids as early biomarkers of neonatal brain injury with an essential role in neuroprotection. Although S-100B seems to be the most studied biomarker, its use in clinical practice is limited by the complexity of brain damage etiopathogenesis and the time of blood sampling in relation to the brain injury. Reliable early specific serum markers are currently lacking in clinical practice. It is essential to determine if there are specific biomarkers that can help caregivers to monitor the progression of the disease in order to active an early neuroprotective strategy. We aimed to describe, in an educational review, the actual evidence on serum biomarkers for the early identification of newborns at a high risk of neurological diseases. To move the biomarkers from the bench to the bedside, the assays must be not only be of a high sensitivity but suitable for the very rapid processing and return of the results for the clinical practice to act on. For the best prognosis, more studies should focus on the association of these biomarkers to the type and severity of perinatal brain damage.
ABSTRACT
A child with a maxillary Ewing sarcoma was operated for tumor asportation and reconstruction with free fibula flap. Adequate anticoagulation was achieved with lower doses of heparin and monitored with multiple ACT values. We used NIRS monitoring to avoid hypoperfusion. Post-operative pain relief was guarantited by local anestethic continous infusion.
ABSTRACT
In this article, we describe the advances in the field of pediatrics that have been published in the Italian Journal of Pediatrics in 2020. We report progresses in understanding allergy, autoinflammatory disorders, critical care, endocrinology, genetics, infectious diseases, microbiota, neonatology, neurology, nutrition, orthopedics, respiratory tract illnesses, rheumatology in childhood.
Subject(s)
Pediatrics/trends , COVID-19 , Child Nutrition Sciences , Critical Care , Endocrinology , Gastrointestinal Microbiome , Humans , Hypersensitivity , Infectious Disease Medicine , Neonatology , Neurology , Orthopedics , Rare Diseases , Respiratory Tract Diseases , RheumatologyABSTRACT
Congenital diaphragmatic hernia (CDH) is a relatively common major life-threatening birth defect that results in significant mortality and morbidity depending primarily on lung hypoplasia, persistent pulmonary hypertension, and cardiac dysfunction. Despite its clinical relevance, CDH multifactorial etiology is still not completely understood. We reviewed current knowledge on normal diaphragm development and summarized genetic mutations and related pathways as well as cellular mechanisms involved in CDH. Our literature analysis showed that the discovery of harmful de novo variants in the fetus could constitute an important tool for the medical team during pregnancy, counselling, and childbirth. A better insight into the mechanisms regulating diaphragm development and genetic causes leading to CDH appeared essential to the development of new therapeutic strategies and evidence-based genetic counselling to parents. Integrated sequencing, development, and bioinformatics strategies could direct future functional studies on CDH; could be applied to cohorts and consortia for CDH and other birth defects; and could pave the way for potential therapies by providing molecular targets for drug discovery.
Subject(s)
Hernias, Diaphragmatic, Congenital/genetics , Diaphragm/embryology , Diaphragm/pathology , Genetic Predisposition to Disease , Hernias, Diaphragmatic, Congenital/classification , Hernias, Diaphragmatic, Congenital/diagnosis , Hernias, Diaphragmatic, Congenital/pathology , High-Throughput Nucleotide Sequencing , Humans , PrognosisABSTRACT
OBJECTIVE: Gastrointestinal (GI) bleeding commonly requires intensive care unit (ICU) in cases of potentialhaemodynamiccompromise or likely urgent intervention. However, manypatientsadmitted to the ICU stop bleeding and do not require further intervention, including blood transfusion. The present work proposes an artificial intelligence (AI) solution for the prediction of rebleeding in patients with GI bleeding admitted to ICU. METHODS: A machine learning algorithm was trained and tested using two publicly available ICU databases, the Medical Information Mart for Intensive Care V.1.4 database and eICU Collaborative Research Database using freedom from transfusion as a proxy for patients who potentially did not require ICU-level care. Multiple initial observation time frames were explored using readily available data including labs, demographics and clinical parameters for a total of 20 covariates. RESULTS: The optimal model used a 5-hour observation period to achieve an area under the curve of the receiving operating curve (ROC-AUC) of greater than 0.80. The model was robust when tested against both ICU databases with a similar ROC-AUC for all. CONCLUSIONS: The potential disruptive impact of AI in healthcare innovation is acknowledge, but awareness of AI-related risk on healthcare applications and current limitations should be considered before implementation and deployment. The proposed algorithm is not meant to replace but to inform clinical decision making. Prospective clinical trial validation as a triage tool is warranted.
Subject(s)
Artificial Intelligence , Blood Transfusion , Gastrointestinal Hemorrhage , Intensive Care Units , Blood Transfusion/statistics & numerical data , Female , Gastrointestinal Hemorrhage/therapy , Humans , Intensive Care Units/statistics & numerical data , Male , Prospective Studies , ROC CurveABSTRACT
BACKGROUND & AIMS: Little is known about the causes of heartburn in patients with gastro-esophageal reflux disease. Visible epithelial damage is seldom associated with symptom severity, evidenced by the significant symptom burden in patients with nonerosive reflux disease (NERD) compared with patients with erosive reflux disease (ERD) or Barrett's esophagus (BE). We studied the distribution of mucosal nerve fibers in patients with NERD, ERD, and BE, and compared the results with those of healthy subjects. METHODS: We performed a prospective study of 13 patients with NERD, 11 patients with ERD, and 16 patients with BE undergoing endoscopic evaluation in the United Kingdom or Greece. Biopsies were obtained from the proximal and distal esophageal mucosa of patients with NERD, from the distal esophageal mucosa of patients with ERD, and the distal-most squamous epithelium of patients with BE. These were examined for the presence and location of nerve fibers that reacted with a labeled antibody against calcitonin gene-related peptide (CGRP), a marker of nociceptive sensory nerves. The results were compared with those from 10 healthy volunteers (controls). RESULTS: The distribution of CGRP-positive nerves did not differ significantly between the distal esophageal mucosa of controls (median, 25.5 cell layers to surface; interquartile range [IQR], 21.4-28.8) vs patients with ERD (median, 23 cell layers to surface; IQR, 16-27.5), or patients with BE (median, 21.5 cell layers to surface; IQR, 16.1-27.5). However, CGRP-positive nerves were significantly more superficial in mucosa from patients with NERD-both distal (median, 9.5 cell layers to surface; IQR, 1.5-13.3; P < .0001 vs ERD, BE, and controls) and proximal (median, 5.0 cell layers to surface; IQR, 2.5-9.3 vs median 10.4 cell layers to surface; IQR, 8.0-16.9; P = .0098 vs controls). CONCLUSIONS: Proximal and distal esophageal mucosa of patients with NERD have more superficial afferent nerves compared with controls or patients with ERD or BE. Acid hypersensitivity in patients with NERD might be partially explained by the increased proximity of their afferent nerves to the esophageal lumen, and therefore greater exposure to noxious substances in refluxate.
Subject(s)
Barrett Esophagus/pathology , Esophageal Mucosa/innervation , Gastroesophageal Reflux/pathology , Heartburn/pathology , Hyperalgesia/pathology , Sensory Receptor Cells/pathology , Adult , Aged , Barrett Esophagus/physiopathology , Biomarkers/analysis , Biopsy , Calcitonin Gene-Related Peptide/analysis , Case-Control Studies , Female , Gastroesophageal Reflux/physiopathology , Greece , Heartburn/physiopathology , Humans , Hyperalgesia/physiopathology , Immunohistochemistry , Male , Middle Aged , Prospective Studies , Sensory Receptor Cells/chemistry , United Kingdom , Young AdultABSTRACT
PURPOSE: The purpose of this study was to describe the association between body image perception and sagittal balance (SB) parameters in Parkinson's Disease (PD) patients. METHODS: 77 consecutive PD patients were included: 44 males, 33 females; 68.9 ± 6.8 years; 5.3 ± 3.8 years from diagnosis (YFD); Hoehn Yahr (HY) 2.0 ± 0.8, Unified Parkinson's Disease rating Score-Motor section (UPDRS-M) 11.8 ± 9.3. Spinopelvic angles and SB were radiographically assessed. Body image perception was assessed through Trunk appearance scale (TAPS) and Stunkard Figure rating scale for BMI. Beck Depression Inventory (BDI) was used to evaluate depressive mood. RESULTS: We detected 32 (41.5 % of cohort) Parkinson Disease patients with scoliosis ≥15° Cobb. The mean calculated BMI was 27.1 ± 3.9 kg/m(2). According to the Figure Rating Scale, the perceived BMI averaged 27.2 ± 4.5 kg/m(2), while the mean desired BMI was 24.4 ± 2.7 kg/m(2), TAPS scored 3.4 ± 0.9 points, while BDI 12.3 ± 7.9 points. TAPS had a weak negative correlation with the duration of disease (r = -0.25, p < 0.05) and a correlation with H&Y score (r = 0.28, p < 0.05). Sacral Slope was weakly correlated to the calculated BMI (r = -0.24, p < 0.05). SSA and SPA had a negative correlation with the TAPS mean score (respectively, r = -0.36 and -0.24, p < 0.05). BDI presented a weak correlation with TAPS (r = 0.27, p < 0.05) but not with self esteemed BMI values (p > 0.05). CONCLUSIONS: Spinopelvic parameters and depression had a specific and concurrent influence on trunk deformity perception but not on BMI self-esteem.